Sid P. Kerkar
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 19
- CAR-T cell therapy research 15
- Cancer Immunotherapy and Biomarkers 6
- Immunology 14
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 7
- T-cell and B-cell Immunology 4
- Co-authors
- Nicholas P. Restifo (14 shared papers)Steven A. Rosenberg (14 shared papers)Richard A. Morgan (6 shared papers)Zhiya Yu (8 shared papers)Pawel Muranski (9 shared papers)Dhanalakshmi Chinnasamy (4 shared papers)Douglas C. Palmer (6 shared papers)Christian S. Hinrichs (6 shared papers)
- Journals
- Blood (5 papers)Clinical Cancer Research (4 papers)Cancer Research (4 papers)Journal of Immunotherapy (3 papers)Molecular Therapy (2 papers)
- Partner nations
- United StatesMalaysiaSpain
In The Last Decade
Sid P. Kerkar
34 papers receiving 2.8k citations
Sid P. Kerkar's Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 2.0k
- Immunology 1.5k
- Genetics 603
- Biotechnology 86
- Biomedical Engineering 400
Countries citing papers authored by Sid P. Kerkar
This map shows the geographic impact of Sid P. Kerkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sid P. Kerkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sid P. Kerkar more than expected).
Fields of papers citing papers by Sid P. Kerkar
This network shows the impact of papers produced by Sid P. Kerkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sid P. Kerkar. The network helps show where Sid P. Kerkar may publish in the future.
Co-authors
The 25 scholars most cited alongside Sid P. Kerkar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma Hit paper breakdown → | 2015 | 352 |
| 2 | 2012 | 291 | |
| 3 | 2011 | 275 | |
| 4 | 2010 | 243 | |
| 5 | 2012 | 241 | |
| 6 | 2011 | 230 | |
| 7 | 2011 | 229 | |
| 8 | 2010 | 215 | |
| 9 | 2015 | 146 | |
| 10 | 2009 | 84 | |
| 11 | 2011 | 77 | |
| 12 | 2016 | 61 | |
| 13 | 2013 | 55 | |
| 14 | 2009 | 50 | |
| 15 | 2004 | 47 | |
| 16 | 2015 | 47 | |
| 17 | 2010 | 44 | |
| 18 | 2005 | 40 | |
| 19 | 2010 | 29 | |
| 20 | 2019 | 17 |
About Sid P. Kerkar
Sid P. Kerkar is a scholar working on Oncology, Immunology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 2.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Virus-based gene therapy research (6 papers), T-cell and B-cell Immunology (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Oncology (2.0k citations), Immunology (1.5k citations), Genetics (603 citations), Biotechnology (86 citations) and Biomedical Engineering (400 citations). Sid P. Kerkar has collaborated with scholars based in United States, Malaysia and Spain. Frequent co-authors include Nicholas P. Restifo, Steven A. Rosenberg, Richard A. Morgan, Zhiya Yu, Pawel Muranski, Dhanalakshmi Chinnasamy, Douglas C. Palmer, Christian S. Hinrichs, Luca Gattinoni and Zachary A. Borman. Their work appears in journals such as Blood, Clinical Cancer Research, Cancer Research, Journal of Immunotherapy and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.